Compared to BLCA with iFGFR3, FGFR3 mRNA expression level was significantly upregulated in patients with recurrent FGFR3 mutations but not in patients with the SNPs (Supplementary Fig. 1E). Here, FGFR3 is linked to bladder transitional cell carcinoma.